Sunil R. Lakhani1, Michael J. O'Hare2
& Alan Ashworth1
1
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research London, UK
2
The Ludwig Institute for Cancer Research London, UK
lakhani@icr.ac.uk
Microarray analysis can be used to differentiate gene expression patterns between various types of tumors, including breast tumors caused by BRCA1 and BRCA2 mutations. But what must be done before this technology can be used in the clinic?
